Literature DB >> 20501851

Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion.

Gunjan Malik1, Lynn M Knowles, Rajiv Dhir, Shuping Xu, Shuting Yang, Erkki Ruoslahti, Jan Pilch.   

Abstract

The attachment of circulating tumor cells to the blood vessels of distant organs is an important step in metastasis. We show here that experimental lung metastasis by two cell lines, B16F1 melanoma and 3LL lung carcinoma, is greatly reduced in transgenic mice that lack plasma fibronectin. This multifunctional adhesive glycoprotein becomes cross-linked to fibrin during clotting. Here, we report that eliminating plasma fibronectin from the blood circulation reverses the prometastatic effects of blood clotting and tumor cell integrin alphavbeta3. In vitro studies showed that fibrin-fibronectin complexes, but not purified fibrin, supported tumor cell attachment and invasion. These functions correlate with the ability of fibrin-fibronectin complexes to induce the activation of integrin alphavbeta3. Our findings reveal an important contribution of plasma fibronectin in lung metastasis. Furthermore, they suggest that the previously noted effects of blood clotting on lung metastasis might be mediated in part by a fibronectin-alphavbeta3 integrin axis, in which plasma fibronectin has to be incorporated into the blood clot. Copyright 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501851      PMCID: PMC2880218          DOI: 10.1158/0008-5472.CAN-09-3312

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  A mechanism for modulation of cellular responses to VEGF: activation of the integrins.

Authors:  T V Byzova; C K Goldman; N Pampori; K A Thomas; A Bett; S J Shattil; E F Plow
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

2.  Presentation of chemokine SDF-1 alpha by fibronectin mediates directed migration of T cells.

Authors:  A J Pelletier; L J van der Laan; P Hildbrand; M A Siani; D A Thompson; P E Dawson; B E Torbett; D R Salomon
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

3.  Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist.

Authors:  H S Ahn; C Foster; G Boykow; A Stamford; M Manna; M Graziano
Journal:  Biochem Pharmacol       Date:  2000-11-15       Impact factor: 5.858

4.  Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis.

Authors:  T Sakai; K J Johnson; M Murozono; K Sakai; M A Magnuson; T Wieloch; T Cronberg; A Isshiki; H P Erickson; R Fässler
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

5.  Genomic analysis of metastasis reveals an essential role for RhoC.

Authors:  E A Clark; T R Golub; E S Lander; R O Hynes
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

6.  Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells.

Authors:  J S Palumbo; K W Kombrinck; A F Drew; T S Grimes; J H Kiser; J L Degen; T H Bugge
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

7.  Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.

Authors:  Jia-Lin Lee; Mei-Jung Wang; Putty-Reddy Sudhir; Gen-Der Chen; Chin-Wen Chi; Jeou-Yuan Chen
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

8.  Integrin activation controls metastasis in human breast cancer.

Authors:  B Felding-Habermann; T E O'Toole; J W Smith; E Fransvea; Z M Ruggeri; M H Ginsberg; P E Hughes; N Pampori; S J Shattil; A Saven; B M Mueller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

9.  SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.

Authors:  Jennifer L Strande; Anna Hsu; Jidong Su; Xiangping Fu; Garrett J Gross; John E Baker
Journal:  Basic Res Cardiol       Date:  2007-04-30       Impact factor: 17.165

10.  Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutation.

Authors:  C P W Klerk; S M Smorenburg; C A Spek; C J F Van Noorden
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

View more
  57 in total

1.  Influence of Stromal Components on Lung Cancer Carcinogenesis.

Authors:  Laurie A Shuman Moss; William G Stetler-Stevenson
Journal:  J Carcinog Mutagen       Date:  2013-06-25

2.  High D-dimer levels are associated with poor prognosis in cancer patients.

Authors:  Cihan Ay; Daniela Dunkler; Robert Pirker; Johannes Thaler; Peter Quehenberger; Oswald Wagner; Christoph Zielinski; Ingrid Pabinger
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

3.  Targeting Fibronectin for Cancer Imaging and Therapy.

Authors:  Zheng Han; Zheng-Rong Lu
Journal:  J Mater Chem B       Date:  2016-12-01       Impact factor: 6.331

4.  Interplay between aging, lung inflammation/remodeling, and fibronectin EDA in lung cancer progression.

Authors:  John C Greenwell; Edilson Torres-Gonzalez; Jeffrey D Ritzenthaler; Jesse Roman
Journal:  Cancer Biol Ther       Date:  2020-11-23       Impact factor: 4.742

5.  CLT1 targets angiogenic endothelium through CLIC1 and fibronectin.

Authors:  Lynn M Knowles; Gunjan Malik; Brian L Hood; Thomas P Conrads; Jan Pilch
Journal:  Angiogenesis       Date:  2011-12-28       Impact factor: 9.596

6.  Fibronectin-targeted dual-acting micelles for combination therapy of metastatic breast cancer.

Authors:  Zhuoran Gong; Min Chen; Qiushi Ren; Xiuli Yue; Zhifei Dai
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

7.  Suspension state regulates epithelial-to-mesenchymal transition and stemness of breast tumor cells.

Authors:  Yonggang Lv; Xiaomei Zhang; Lini Chen
Journal:  Biotechnol Lett       Date:  2021-01-02       Impact factor: 2.461

8.  A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients.

Authors:  Seon-Kyu Kim; Seon-Young Kim; Jeong-Hwan Kim; Seon Ae Roh; Dong-Hyung Cho; Yong Sung Kim; Jin Cheon Kim
Journal:  Mol Oncol       Date:  2014-07-04       Impact factor: 6.603

9.  Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches.

Authors:  Jess D Hebert; Samuel A Myers; Alexandra Naba; Genevieve Abbruzzese; John M Lamar; Steven A Carr; Richard O Hynes
Journal:  Cancer Res       Date:  2020-02-04       Impact factor: 12.701

10.  Integrin αvβ3 and fibronectin upregulate Slug in cancer cells to promote clot invasion and metastasis.

Authors:  Lynn M Knowles; Lisa A Gurski; Charlotte Engel; James R Gnarra; Jodi K Maranchie; Jan Pilch
Journal:  Cancer Res       Date:  2013-08-21       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.